Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
Gross Profit
Santen Pharmaceutical Co Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Gross Profit
¥178.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Gross Profit
¥2.8T
|
CAGR 3-Years
9%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Gross Profit
¥1.2T
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Gross Profit
¥1.5T
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Gross Profit
¥701.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
17%
|
CAGR 10-Years
11%
|
|
Astellas Pharma Inc
TSE:4503
|
Gross Profit
¥1.3T
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
See Also
What is Santen Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
178.7B
JPY
Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's Gross Profit amounts to 178.7B JPY.
What is Santen Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
7%
Over the last year, the Gross Profit growth was 8%. The average annual Gross Profit growth rates for Santen Pharmaceutical Co Ltd have been 6% over the past three years , 5% over the past five years , and 7% over the past ten years .